| Bioactivity | DOTA-ubiquicidin (29-41), an antimicrobial peptide fragment derivative, can be used for synthesis of [68Ga]Ga-DOTA-Ubiquicidin29-41 and then used for imaging of infectious processes using PET/CT[1]. |
| Sequence | DOTA-Thr-Gly-Arg-Ala-Lys-Arg-Arg-Met-Gln-Tyr-Asn-Arg-Arg |
| Shortening | DOTA-TGRAKRRMQYNRR |
| Formula | C84H147N35O25S |
| Molar Mass | 2079.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Miranda ACC, et al. Radiosynthesis Standardization and Preclinical Assessment of the [68Ga]Ga-DOTA-Ubiquicidin29-41: A Translational Study Targeting Differential Diagnosis of Infectious Processes. Pharmaceuticals (Basel). 2023 Dec 28;17(1):48. |
DOTA-ubiquicidin (29–41)
CAS: F: C84H147N35O25S W: 2079.35
DOTA-ubiquicidin (29-41), an antimicrobial peptide fragment derivative, can be used for synthesis of Ga-DOTA-Ubiquicidin
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.